aTyr Pharma | LIFE - Passivo Circulante





Passivo Circulante Alterar Data
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Ardelyx USD 109.57M 20.96M 2026-03
aTyr Pharma USD 11.4M 303K 2026-06
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Curis USD 14.97M 898K 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
Grifols EUR 2.37B 156.97M 2025-12
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Novartis USD 31.75B 374M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06